Advancing multiple-myeloma and blood-cancer dx with WGS - On Target Podcast w/ Irene Ghobrial, Co-Founder, Predicta Biosciences

Using biomarkers to monitor multiple sclerosis - On Target Podcast w/ Doug Biehn, President and CEO, Octave Biosciences

Doug Biehn, President and CEO of Octave Biosciences, talks about the difference that a biomarker test can make in the management of multiple sclerosis.

Identifying hard-to-diagnose infections in cancer patients - On Target Podcast w/ Alec Ford, CEO, Karius

Alec Ford, CEO of Karius, shares how genomics and AI are expanding what's possible in infectious disease diagnostics — and why getting the right answer faster can make all the difference for immunocompromised patients battling cancer and other serious conditions.

Advancing multiple-myeloma and blood-cancer dx with WGS - On Target Podcast w/ Irene Ghobrial, Co-Founder, Predicta Biosciences

Irene Ghobrial, founder of Predicta Biosciences, explains how bringing whole-genome sequencing into the clinic is taking diagnosis and treatment of multiple myeloma and blood cancers to a new level of precision.

"Expanding genomic analysis with optical genome mapping - On Target Podcast w/ Alka Chaubey CMO, Bionano Genomics"

Alka Chaubey, CMO of Bionano Genomics, explains how optical genome mapping addresses the unmet needs of cytogenomics - and what it takes to get pathbreaking new technology into the clinic.

Using fragmentomics for early cancer detection - On Target Podcast w/ Susan Tousi CEO of Delfi

Susan Tousi, CEO of DELFI Diagnostics, shares how her company is using AI and fragmentomics to make liquid biopsy more accessible and cancer less deadly.